UCLA Health Westwood Cancer Care

Los Angeles, California 90095

0 studies enrolling now · 2 studies all time

What they study most

Advanced Cutaneous Melanoma, Advanced Unresectable Solid Tumor, Metastatic Solid Tumor

Studies at this site

• ITIL-168 in Advanced Melanoma — Stopped early
• Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies — Status unconfirmed